Condition: Drug Use · Substance Abuse · Mental Illness · Sponsor: NYU Langone Health
The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).
This description comes directly from the study's public registry record.
Ayana Jordan, MD, PhD · (203) 787-8032 · Ayana.Jordan@nyulangone.org
Always discuss trial participation with your own doctor first.
| Yale University | New Haven, Connecticut, United States | Recruiting |
| NYU Langone Health | New York, New York, United States | Not Yet Recruiting |
| Nathan Kline Institute | Orangeburg, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05776316